JIN Ev To Free Cash Flow vs Free Cash Flow Yield Analysis

ZJYL Stock

0.88 0.07 7.37%

JIN MEDICAL financial indicator trend analysis is infinitely more than just investigating JIN MEDICAL INTERNATIONAL recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether JIN MEDICAL INTERNATIONAL is a good investment. Please check the relationship between JIN MEDICAL Ev To Free Cash Flow and its Free Cash Flow Yield accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in JIN MEDICAL INTERNATIONAL. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

Ev To Free Cash Flow vs Free Cash Flow Yield

Ev To Free Cash Flow vs Free Cash Flow Yield Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of JIN MEDICAL INTERNATIONAL Ev To Free Cash Flow account and Free Cash Flow Yield. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between JIN MEDICAL's Ev To Free Cash Flow and Free Cash Flow Yield is 0.54. Overlapping area represents the amount of variation of Ev To Free Cash Flow that can explain the historical movement of Free Cash Flow Yield in the same time period over historical financial statements of JIN MEDICAL INTERNATIONAL, assuming nothing else is changed. The correlation between historical values of JIN MEDICAL's Ev To Free Cash Flow and Free Cash Flow Yield is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ev To Free Cash Flow of JIN MEDICAL INTERNATIONAL are associated (or correlated) with its Free Cash Flow Yield. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow Yield has no effect on the direction of Ev To Free Cash Flow i.e., JIN MEDICAL's Ev To Free Cash Flow and Free Cash Flow Yield go up and down completely randomly.

Correlation Coefficient

0.54

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Ev To Free Cash Flow

A valuation metric comparing the company's enterprise value to its free cash flow, used to evaluate whether a company is undervalued or overvalued.

Free Cash Flow Yield

A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.

Most indicators from JIN MEDICAL's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into JIN MEDICAL INTERNATIONAL current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in JIN MEDICAL INTERNATIONAL. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

At this time, JIN MEDICAL's Selling General Administrative is quite stable compared to the past year. Issuance Of Capital Stock is expected to rise to about 9.7 M this year, although the value of Tax Provision will most likely fall to about 213.3 K.

	2023	2024 (projected)
Interest Expense	8.5K	8.1K
Depreciation And Amortization	198.9K	254.1K

Interest Expense Depreciation And Amortization

JIN MEDICAL fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets
Total Assets		0.78	-0.86	-0.36	0.98	0.84	-0.86	-0.44	-0.54	0.89	-0.87	0.93	-0.89	0.04	0.8	0.91	-0.36	0.5	0.92	-0.66	0.63	0.84	-0.36	1.0	0.78	-0.84
Short Long Term Debt Total	0.78		-0.89	-0.74	0.88	0.98	-0.89	-0.1	-0.9	0.93	-0.69	0.94	-0.86	0.58	0.91	0.76	-0.64	0.35	0.7	-0.24	0.86	0.46	-0.74	0.8	1.0	-0.66
Other Current Liab	-0.86	-0.89		0.69	-0.93	-0.95	0.97	0.37	0.84	-0.99	0.77	-0.95	0.95	-0.48	-0.98	-0.87	0.73	-0.5	-0.84	0.29	-0.91	-0.59	0.69	-0.87	-0.89	0.8
Total Current Liabilities	-0.36	-0.74	0.69		-0.52	-0.76	0.76	0.13	0.91	-0.69	0.52	-0.63	0.72	-0.72	-0.72	-0.59	0.78	0.0	-0.5	-0.01	-0.79	-0.24	1.0	-0.38	-0.74	0.61
Total Stockholder Equity	0.98	0.88	-0.93	-0.52		0.93	-0.93	-0.41	-0.7	0.96	-0.88	0.99	-0.95	0.21	0.89	0.92	-0.51	0.52	0.9	-0.56	0.74	0.77	-0.52	0.98	0.88	-0.84
Net Tangible Assets	0.84	0.98	-0.95	-0.76	0.93		-0.95	-0.25	-0.9	0.98	-0.77	0.97	-0.93	0.54	0.96	0.83	-0.66	0.36	0.78	-0.3	0.89	0.55	-0.76	0.85	0.98	-0.76
Property Plant And Equipment Net	-0.86	-0.89	0.97	0.76	-0.93	-0.95		0.45	0.84	-0.98	0.88	-0.96	0.99	-0.4	-0.94	-0.93	0.72	-0.43	-0.89	0.43	-0.85	-0.69	0.76	-0.87	-0.89	0.9
Current Deferred Revenue	-0.44	-0.1	0.37	0.13	-0.41	-0.25	0.45		0.01	-0.35	0.68	-0.37	0.48	0.37	-0.32	-0.44	0.07	-0.23	-0.47	0.57	-0.06	-0.55	0.13	-0.44	-0.1	0.63
Net Debt	-0.54	-0.9	0.84	0.91	-0.7	-0.9	0.84	0.01		-0.84	0.55	-0.8	0.8	-0.78	-0.86	-0.67	0.87	-0.3	-0.59	-0.01	-0.91	-0.28	0.91	-0.56	-0.9	0.58
Retained Earnings	0.89	0.93	-0.99	-0.69	0.96	0.98	-0.98	-0.35	-0.84		-0.81	0.98	-0.96	0.45	0.98	0.89	-0.67	0.45	0.85	-0.36	0.89	0.63	-0.69	0.9	0.93	-0.82
Accounts Payable	-0.87	-0.69	0.77	0.52	-0.88	-0.77	0.88	0.68	0.55	-0.81		-0.87	0.91	0.05	-0.7	-0.9	0.44	-0.45	-0.9	0.78	-0.5	-0.88	0.52	-0.87	-0.69	0.94
Cash	0.93	0.94	-0.95	-0.63	0.99	0.97	-0.96	-0.37	-0.8	0.98	-0.87		-0.96	0.34	0.93	0.9	-0.61	0.51	0.87	-0.48	0.8	0.7	-0.63	0.94	0.94	-0.83
Non Current Assets Total	-0.89	-0.86	0.95	0.72	-0.95	-0.93	0.99	0.48	0.8	-0.96	0.91	-0.96		-0.31	-0.91	-0.96	0.67	-0.44	-0.93	0.52	-0.8	-0.76	0.72	-0.9	-0.86	0.93
Non Currrent Assets Other	0.04	0.58	-0.48	-0.72	0.21	0.54	-0.4	0.37	-0.78	0.45	0.05	0.34	-0.31		0.59	0.13	-0.67	-0.03	0.03	0.62	0.77	-0.34	-0.72	0.06	0.58	-0.03
Other Assets	0.8	0.91	-0.98	-0.72	0.89	0.96	-0.94	-0.32	-0.86	0.98	-0.7	0.93	-0.91	0.59		0.79	-0.71	0.4	0.74	-0.16	0.95	0.47	-0.72	0.81	0.91	-0.73
Cash And Short Term Investments	0.91	0.76	-0.87	-0.59	0.92	0.83	-0.93	-0.44	-0.67	0.89	-0.9	0.9	-0.96	0.13	0.79		-0.57	0.43	0.99	-0.65	0.7	0.89	-0.59	0.91	0.76	-0.96
Net Receivables	-0.36	-0.64	0.73	0.78	-0.51	-0.66	0.72	0.07	0.87	-0.67	0.44	-0.61	0.67	-0.67	-0.71	-0.57		-0.54	-0.5	-0.1	-0.78	-0.22	0.78	-0.38	-0.64	0.48
Common Stock Shares Outstanding	0.5	0.35	-0.5	0.0	0.52	0.36	-0.43	-0.23	-0.3	0.45	-0.45	0.51	-0.44	-0.03	0.4	0.43	-0.54		0.44	-0.29	0.27	0.41	0.0	0.51	0.35	-0.28
Short Term Investments	0.92	0.7	-0.84	-0.5	0.9	0.78	-0.89	-0.47	-0.59	0.85	-0.9	0.87	-0.93	0.03	0.74	0.99	-0.5	0.44		-0.71	0.64	0.93	-0.5	0.91	0.7	-0.95
Inventory	-0.66	-0.24	0.29	-0.01	-0.56	-0.3	0.43	0.57	-0.01	-0.36	0.78	-0.48	0.52	0.62	-0.16	-0.65	-0.1	-0.29	-0.71		0.06	-0.91	-0.01	-0.65	-0.24	0.7
Other Current Assets	0.63	0.86	-0.91	-0.79	0.74	0.89	-0.85	-0.06	-0.91	0.89	-0.5	0.8	-0.8	0.77	0.95	0.7	-0.78	0.27	0.64	0.06		0.3	-0.79	0.65	0.86	-0.6
Other Stockholder Equity	0.84	0.46	-0.59	-0.24	0.77	0.55	-0.69	-0.55	-0.28	0.63	-0.88	0.7	-0.76	-0.34	0.47	0.89	-0.22	0.41	0.93	-0.91	0.3		-0.24	0.83	0.46	-0.89
Total Liab	-0.36	-0.74	0.69	1.0	-0.52	-0.76	0.76	0.13	0.91	-0.69	0.52	-0.63	0.72	-0.72	-0.72	-0.59	0.78	0.0	-0.5	-0.01	-0.79	-0.24		-0.38	-0.74	0.61
Total Current Assets	1.0	0.8	-0.87	-0.38	0.98	0.85	-0.87	-0.44	-0.56	0.9	-0.87	0.94	-0.9	0.06	0.81	0.91	-0.38	0.51	0.91	-0.65	0.65	0.83	-0.38		0.8	-0.84
Short Term Debt	0.78	1.0	-0.89	-0.74	0.88	0.98	-0.89	-0.1	-0.9	0.93	-0.69	0.94	-0.86	0.58	0.91	0.76	-0.64	0.35	0.7	-0.24	0.86	0.46	-0.74	0.8		-0.66
Intangible Assets	-0.84	-0.66	0.8	0.61	-0.84	-0.76	0.9	0.63	0.58	-0.82	0.94	-0.83	0.93	-0.03	-0.73	-0.96	0.48	-0.28	-0.95	0.7	-0.6	-0.89	0.61	-0.84	-0.66

Click cells to compare fundamentals

JIN MEDICAL Account Relationship Matchups

JIN MEDICAL fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	20.8M	21.9M	20.9M	32.9M	37.8M	27.5M
Other Current Liab	754.8K	725.1K	511.8K	319.6K	287.7K	530.0K
Total Current Liabilities	10.0M	7.9M	5.7M	8.9M	8.0M	6.8M
Total Stockholder Equity	10.8M	14.0M	15.2M	24.0M	27.6M	18.1M
Property Plant And Equipment Net	2.3M	2.1M	1.6M	1.5M	1.3M	1.5M
Current Deferred Revenue	975.7K	1.7M	830.3K	829.2K	746.3K	854.1K
Net Debt	983.7K	(3.7M)	(4.8M)	(2.8M)	(2.5M)	(2.7M)
Retained Earnings	9.6M	11.9M	14.4M	16.9M	19.5M	14.2M
Accounts Payable	5.4M	5.4M	4.1M	3.4M	3.1M	3.5M
Cash	1.7M	3.7M	4.8M	6.9M	8.0M	4.8M
Non Current Assets Total	2.7M	2.5M	2.0M	1.8M	1.6M	1.8M
Non Currrent Assets Other	366.4K	857.3K	864.6K	152.5K	175.3K	166.6K
Cash And Short Term Investments	2.8M	5.7M	7.1M	16.7M	19.2M	20.2M
Net Receivables	7.9M	6.0M	4.3M	4.2M	8.5M	5.3M
Short Term Investments	1.2M	2.1M	2.3M	9.8M	11.2M	11.8M
Liabilities And Stockholders Equity	20.8M	21.9M	20.9M	32.9M	37.8M	25.7M
Inventory	7.0M	6.9M	6.7M	5.1M	4.5M	4.9M
Other Current Assets	758.9K	969.6K	1.0M	863.7K	993.3K	866.7K
Total Liab	10.0M	7.9M	5.7M	8.9M	8.0M	6.8M
Total Current Assets	18.2M	19.4M	18.9M	31.1M	35.8M	25.0M
Accumulated Other Comprehensive Income	1.1M	2.1M	740.3K	606.5K	545.9K	885.5K
Intangible Assets	180.9K	185.1K	163.2K	154.4K	138.9K	135.4K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether JIN MEDICAL INTERNATIONAL is a strong investment it is important to analyze JIN MEDICAL's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact JIN MEDICAL's future performance. For an informed investment choice regarding JIN Stock, refer to the following important reports:

How To Invest In JIN

Details

Is JIN Stock a good investment?

Details

What is JIN MEDICAL's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in JIN MEDICAL INTERNATIONAL. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of JIN MEDICAL. If investors know JIN will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about JIN MEDICAL listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.12)

Earnings Share

0.02

Revenue Per Share

0.129

Quarterly Revenue Growth

0.03

Return On Assets

0.0403

The market value of JIN MEDICAL INTERNATIONAL is measured differently than its book value, which is the value of JIN that is recorded on the company's balance sheet. Investors also form their own opinion of JIN MEDICAL's value that differs from its market value or its book value, called intrinsic value, which is JIN MEDICAL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because JIN MEDICAL's market value can be influenced by many factors that don't directly affect JIN MEDICAL's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between JIN MEDICAL's value and its price as these two are different measures arrived at by different means. Investors typically determine if JIN MEDICAL is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, JIN MEDICAL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

JIN Ev To Free Cash Flow vs Free Cash Flow Yield Analysis

Ev To Free Cash Flow vs Free Cash Flow Yield

Ev To Free Cash Flow vs Free Cash Flow Yield Correlation Analysis

Correlation Coefficient

Ev To Free Cash Flow

Free Cash Flow Yield

JIN MEDICAL fundamental ratios Correlations

JIN MEDICAL Account Relationship Matchups

High Positive Relationship

High Negative Relationship

JIN MEDICAL fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Short Term Debt	+ 1.0	Short Long Term Debt Total
Total Liab	+ 1.0	Total Current Liabilities
Cash	+ 0.99	Total Stockholder Equity
Non Current Assets Total	+ 0.99	Property Plant And Equipment Net
Short Term Investments	+ 0.99	Cash And Short Term Investments

Retained Earnings	- 0.99	Other Current Liab
Retained Earnings	- 0.98	Property Plant And Equipment Net
Other Assets	- 0.98	Other Current Liab
Intangible Assets	- 0.96	Cash And Short Term Investments
Cash And Short Term Investments	- 0.96	Non Current Assets Total
Non Current Assets Total	- 0.96	Cash